2.88
Schlusskurs vom Vortag:
$3.01
Offen:
$2.91
24-Stunden-Volumen:
3.29M
Relative Volume:
0.79
Marktkapitalisierung:
$152.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.58M
KGV:
-2.40
EPS:
-1.2
Netto-Cashflow:
$-9.21M
1W Leistung:
-10.53%
1M Leistung:
-28.64%
6M Leistung:
+26.75%
1J Leistung:
+200.60%
Microbot Medical Inc Stock (MBOT) Company Profile
Firmenname
Microbot Medical Inc
Sektor
Telefon
908-938-5561
Adresse
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Vergleichen Sie MBOT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MBOT
Microbot Medical Inc
|
2.88 | 158.91M | 0 | -10.58M | -9.21M | -1.20 |
![]()
ISRG
Intuitive Surgical Inc
|
436.39 | 156.20B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
188.35 | 53.50B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
270.15 | 39.84B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
74.08 | 35.89B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
261.26 | 18.87B | 2.96B | 487.70M | 344.00M | 6.6758 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-01-13 | Bestätigt | H.C. Wainwright | Buy |
2019-12-24 | Bestätigt | H.C. Wainwright | Buy |
2018-01-31 | Eingeleitet | Ladenburg Thalmann | Buy |
Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten
Microbot Medical (MBOT) Partners to Launch LIBERTY System - GuruFocus
Microbot Medical Partners for LIBERTY System Launch - TipRanks
Microbot Medical Inc Partners for LIBERTY® System Commercialization - TradingView
Microbot Medical partners with logistics firm for LIBERTY system launch - Investing.com
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System - The Manila Times
Microbot Medical® Secures U.S. Based Logistics Partner to - GlobeNewswire
Limited Q4 2025 LIBERTY release — Microbot Medical secures U.S. logistics partner ahead of April 2026 launch - Stock Titan
Microbot Medical Inc files for offering of up to 14.7 million shares of common stock by the selling stockholdersSEC filing - MarketScreener
What risks investors should watch in Microbot Medical Inc. stockTrade Entry Summary & High Accuracy Trade Alerts - newser.com
Real time scanner hits for Microbot Medical Inc. explainedWatch List & Long Hold Capital Preservation Plans - newser.com
Microbot Medical (NASDAQ:MBOT) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Is Microbot Medical Inc. (CY9D) stock at risk of policy regulationMarket Performance Report & Free Expert Approved Momentum Trade Ideas - newser.com
Why Microbot Medical Inc. (CY9D) stock fits value portfolios2025 Year in Review & Smart Allocation Stock Reports - newser.com
Visual trend scoring systems applied to Microbot Medical Inc.2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
How to forecast Microbot Medical Inc. trends using time seriesStop Loss & Technical Pattern Based Signals - newser.com
Using flow based indicators on Microbot Medical Inc.July 2025 Opening Moves & Stock Market Timing Techniques - newser.com
Microbot Medical Inc.’s volatility index tracking explained2025 Historical Comparison & Reliable Trade Execution Plans - newser.com
Will Microbot Medical Inc. rebound enough to break even2025 Market Overview & Fast Gain Swing Alerts - newser.com
Microbot Medical Inc. stock momentum explainedMarket Movers & Fast Entry High Yield Tips - newser.com
Microbot Medical closes stock sale with $29.2M raised - The Robot Report
Microbot Medical Announces Final Closing of Exercise of - GlobeNewswire
Microbot Medical Completes Final Closing of Investment Options - TipRanks
Microbot Medical Inc. Completes Final Closing of Preferred Investment Options, Raising Approximately $25.2 Million - Quiver Quantitative
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds - The Manila Times
Press Release: Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds - 富途牛牛
Will Microbot Medical Inc. (CY9D) stock gain from green policiesJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Q3 EPS Estimate for Microbot Medical Increased by Analyst - MarketBeat
Microbot Medical Inc. stock prediction for this weekWeekly Trade Recap & Real-Time Stock Movement Alerts - newser.com
Microbot Medical Announces Series H Options Exercise - The Globe and Mail
Microbot Medical (NASDAQ:MBOT) Upgraded at Wall Street Zen - MarketBeat
Microbot Medical issues new equity options and common stock through private placements - Investing.com
Real time alert setup for Microbot Medical Inc. performance2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
Best data tools to analyze Microbot Medical Inc. stockJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Microbot Medical receives first Japanese patent for LIBERTY - The Robot Report
Microbot Medical Receives First Patent in Japan as it continues to broaden its Global Intellectual Property Portfolio - MarketScreener
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio - GlobeNewswire
Microbot Medical®? Receives First Patent in Japan as It Continues to Broaden Its Global Intellectual Property Portfolio - MarketScreener
Microbot Medical receives first patent in Japan for LIBERTY SystemSEC FILING - MarketScreener
Microbot Medical (MBOT) Secures First Patent in Japan for LIBERT - GuruFocus
Microbot Medical secures patent in Japan for Liberty endovascular robotic system - Vascular News
Microbot Medical Secures First Japanese Patent for LIBERTY® - TipRanks
Microbot Medical Inc. Expands Focus on U.S. Market Following Patent Grant in Japan and FDA Clearance for LIBERTY® System - Quiver Quantitative
Finanzdaten der Microbot Medical Inc-Aktie (MBOT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):